Detailed Information

Cited 1 time in webofscience Cited 0 time in scopus
Metadata Downloads

The inhibition of TREK2 channel by an oxidizing agent, 5,5 '-dithiobis (2-nitrobenzoic acid), via interaction with the c-terminus distal to the 353rd amino acid

Full metadata record
DC Field Value Language
dc.contributor.authorPark, Kyoung Sun-
dc.contributor.authorBang, Hyoweon-
dc.contributor.authorShin, Eun-Young-
dc.contributor.authorKim, Chan Hyung-
dc.contributor.authorKim, Yangmi-
dc.date.available2019-05-30T04:40:07Z-
dc.date.issued2008-08-
dc.identifier.issn1226-4512-
dc.identifier.issn2093-3827-
dc.identifier.urihttps://scholarworks.bwise.kr/cau/handle/2019.sw.cau/23660-
dc.description.abstractTREK (TWIK-RElated K+ channels) and TRAAK (TWIK-Related Arachidonic acid Activated K+ channels) were expressed in COS-7 cells, and the channel activities were recorded from inside-out membrane patches using holding potential of -40 mV in symmetrical 150 mM K+ solution. Intracellular application of an oxidizing agent, 5,5'-dithio-bis (2-nitrobenzoic acid) (DTNB), markedly decreased the activity of the TREK2, and the activity was partially reversed by the reducing agent, dithiothreitol (DTT). In order to examine the possibility that the target sites for the oxidizing agents might be located in the C-terminus of TREK2, two chimeras were constructed: TREK2 (1-383)/TASK3C and TREK2 (1-353)/TASK3C. The channel activity in the TREK2 (1-383)/TASK3C chimera was still inhibited by DTNB, but not in the TREK2 (1-353)/TASK3C chimera. These results indicate that TREK2 is inhibited by oxidation, and that the target site for oxidation is located between the amino acid residues 353 and 383 in the C-terminus of the TREK2 protein.-
dc.format.extent6-
dc.language영어-
dc.language.isoENG-
dc.publisherKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY-
dc.titleThe inhibition of TREK2 channel by an oxidizing agent, 5,5 '-dithiobis (2-nitrobenzoic acid), via interaction with the c-terminus distal to the 353rd amino acid-
dc.typeArticle-
dc.identifier.doi10.4196/kjpp.2008.12.4.211-
dc.identifier.bibliographicCitationKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, v.12, no.4, pp 211 - 216-
dc.identifier.kciidART001275170-
dc.description.isOpenAccessY-
dc.identifier.wosid000259112300013-
dc.identifier.scopusid2-s2.0-52249091094-
dc.citation.endPage216-
dc.citation.number4-
dc.citation.startPage211-
dc.citation.titleKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY-
dc.citation.volume12-
dc.type.docTypeArticle-
dc.publisher.location대한민국-
dc.subject.keywordAuthorTREK2-
dc.subject.keywordAuthoroxidizing agent-
dc.subject.keywordAuthor5,5 '-dithio-bis(2-nitrobenzoic acid) (DTNB)-
dc.subject.keywordAuthordithiothreitol (DTT)-
dc.subject.keywordAuthorC-terminus-
dc.subject.keywordAuthortwo-pore domain K+ channel-
dc.subject.keywordAuthorK-2P-
dc.subject.keywordPlusK+ CHANNEL-
dc.subject.keywordPlusPOTASSIUM CHANNELS-
dc.subject.keywordPlusREDOX MODULATION-
dc.subject.keywordPlusFATTY-ACIDS-
dc.subject.keywordPlusHYPOXIA-
dc.subject.keywordPlusNEUROPROTECTION-
dc.subject.keywordPlusACTIVATION-
dc.subject.keywordPlusOXIDATION-
dc.subject.keywordPlusPRESSURE-
dc.subject.keywordPlusHTREK1-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaPhysiology-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPhysiology-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
Files in This Item
Appears in
Collections
College of Medicine > College of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE